Researchers Challenged Serum Selection Methods
New findings show that geographical origin fails to predict the functional performance of fetal bovine serum.
Updated on Sept. 21, 2026 in Life Sciences
Scientists have introduced a molecular assessment strategy to evaluate fetal bovine serum, a critical component in cell culture research. The study concluded that traditional batch selection based on origin does not reliably predict performance.
Why it matters
Current methods for selecting serum are costly and labor-intensive because batches vary significantly. A more precise assessment strategy could reduce reliance on trial-and-error batch testing.
Researchers utilized transcriptomic and cytokine profiling across 3 cell lines—MRC-5, Jurkat, and THP-1—to categorize batch performance. The data revealed that immune-related pathways exhibit the highest level of variability between different serum batches.
The players
MRC-5
This is a human lung fibroblast cell line frequently utilized in laboratory research and vaccine production.
Jurkat
This is an immortalized line of human T lymphocyte cells that is commonly used to study acute T cell leukemia and immune cell signaling.
THP-1
This is a human monocytic cell line derived from an acute monocytic leukemia patient and is often used in immunology research.
The details
The research team demonstrated that standardized Certificate of Analysis parameters do not correlate with actual cytokine secretion or gene expression levels in cultured cells. By shifting toward functional transcriptomic profiling, labs may better identify serum batches that meet their specific experimental requirements.
Timeline
The article detailing these research findings was published on September 21, 2026.
The Big Picture
This research challenges the long-standing industry standard of using the historical reliance on Certificate of Analysis parameters for quality control. It suggests a paradigm shift toward functional, cell-based molecular assessment to overcome the limitations of traditional origin-based grading.
Adopting these molecular assessment protocols could eventually standardize laboratory reagent selection and improve experimental reproducibility. Researchers may see a shift in procurement practices as data-driven functional profiling replaces older, less reliable origin-based metrics.
The takeaway
Laboratories should move away from relying exclusively on geographical origin labels when sourcing critical biological reagents. Implementing functional profiling can save significant time and money by identifying batch variation before experiments begin.
Further reading
Explore more breakthroughs in cell culture and experimental techniques in our Life Sciences section.
More information
Review the original study findings by visiting the Permanent DOI for research article.
Source note: This article includes information reported by Nature.
